(3.238.186.43) 您好!臺灣時間:2021/02/28 21:01
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:常宏傳
研究生(外文):Hung-Chuan, Chang
論文名稱:全身性紅斑狼瘡病人血清中的抗體抑制去氧核糖核酸的作用
論文名稱(外文):Deoxyribonuclease inhibitory antibodies in systemic lupus erythematosus
指導教授:葉才明
學位類別:碩士
校院名稱:國立成功大學
系所名稱:微生物暨免疫學研究所
學門:生命科學學門
學類:微生物學類
論文種類:學術論文
論文出版年:1998
畢業學年度:86
語文別:中文
論文頁數:73
中文關鍵詞:全身性紅斑狼瘡症去氧核糖核酸抗去氧核糖核酸抗體
外文關鍵詞:SLEDNase Ianti-DNase antibodies
相關次數:
  • 被引用被引用:0
  • 點閱點閱:125
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:1
全身性紅斑狼瘡 (Systemic Lupus Erythematosus, SLE) 是屬於典
型的全身性自體免疫疾病,其特色是在 SLE 病人血清中產生針對抗核抗
體。 DNase 是一種核酸內切,其主要的功能在於能夠將去氧核糖核
酸 (DNA) 水解,在正常人類的血液及尿液中此都存在。 在我們的研
究中顯示當利用酵素免疫分析的方式檢測 anti-DNase antibodies大約
有 62.4% 的SLE 病人是呈現陽性反應﹔而在抗核抗體為陰性的對照組
血清中僅 8% 為陽性反應。 另外 SLE 病人血清中 anti-DNase
antibodies 與 anti-DNA antibodies 是呈現正相關。 我們也收集
SLE 病人的血清經由親和性管柱純化的方式純化 anti-DNase IgG,
此種抗體經由酵素免疫法測試可以結合至 DNase 及 DNA﹔若將合成的
DNase peptide 與牛胰臟 DNase I 進行競爭性試驗則可以抑制與
anti-DNase IgG 和牛的 DNase I 結合。 當我們利用親和性管柱所
純化的 anti-DNase IgG 做間接免疫螢光分析法時,發現以 Hep-2
細胞作為受質時會呈現斑點型及核仁型的分佈,但不會在鞭毛蟲
(Crithidia luciliae) 作為受質時不會和其 kinetoplast 結合。
進一步利用親和性管柱所純化的 anti-DNase IgG 比正常人血清所
純化的 IgG 更明顯抑制鏈球菌、牛、人的 DNase 活性。 值得注意
的是,若利用牛的 DNase I 去免疫 BALB/c 及 NZB/NZW 老鼠所產生
的 anti-DNase antibodies 及 anti-DNA antibodies 的效價都較正
常之未被免疫老鼠來的高。此外,取用牛的 DNase I 免疫 BALB/c老
鼠的腎臟做組織學切片,發現在老鼠腎管壁有纖維細胞的替代。
綜合以上結果我們認為,anti-DNase antibodies 普遍存在於 SLE
病人血清中,並且經由親和性管柱所純化的此種 anti-DNase
antibodies 可以抑制 DNase的活性。 因此推測在 SLE 病人血清中,
可能由於 anti-DNase antibodies 的存在而抑制 DNase 水解 DNA
的活性,進而刺激或促進 anti-DNA antibodies的產生。

英文摘要
Systemic lupus erythematosus (SLE) is a prototypic systemic
autoimmune disease characterized by the production of
autoantibodies against nuclear components . Dexoxyribonuclease I
(DNase I), an endonuclease capable of hydrolyzing of DNA, is
normally present in human serum and urine. In our study,
antibodies binding to bovine DNase I were investigated by ELISA
in SLE patients and anti-nuclear antibody (ANA) negative
normal sera. About 62.4% of SLE patients (63/101) were positive
for anti-DNase antibodies while only 8% of normal controls
(8/98) were positive. A positive correlation was found between
the concentrations of anti-DNase and anti-DNA antibodies in
SLE patients. Affinity-purified anti-DNase IgG from pooled SLE
patients serum and BALB/c mice immunized with bovine DNase
bound to DNase as well as DNA coated ELISA plates. A synthetic
peptide which cross-response to the catalytic site of DNase was
able to completely inhibit anti-DNase IgG bound to DNase but
not DNA coated plate. Indirect immunofluorescence of anti-DNase
IgG displayed speckled and nucleolar patterns of Hep-2 cells
but no reaction to the kinetoplast DNA in Crithidia luciliae.
In addition to bovine DNase, anti-DNase IgG also bound to DNase
in streptococcal supernatants and human urine and inhibited
their enzymatic activities . It was also noticed that BALB/c
and NZB/NZW mice immunized with bovine DNase I produced more
anti-DNase and anti-DNA antibodies than na鴳e mice. Besides,
immunized BALB/c mice showed fibroblast cells in renal tubule
walls under histological examination showed.Based on the
data above, we conclude that it is possible that the
inhibition of DNase I activity by the anti-DNase antibodies
may cause a defect in DNA degradation and stimulate or
enhance anti-DNA antibodies production.

目錄
中文摘要
英文摘要
誌謝
縮寫
圖目錄
前言
實驗設計
材料與方法
一、材料與方法
I. 人類血清
II. 實驗動物
III. Peptides的合成
IV. 酵素免疫
V. 親和性管柱層析法
VI. 測定抗體濃度
VII. 間接免疫螢光染色法
VIII. 硫酸十二酯鈉-聚丙烯醯氨膠電泳法
IX. 西方點墨法
X. 酵素活性膠體試驗
XI. 抗體抑制 DNase 活性試驗
XII. 免疫小鼠
XIII腎臟組織學切片
二、試藥與儀器
結果
I. 檢測 SLE 病人血清中的 anti-DNase antibodies
II. Anti-DNase IgG的特性
III. Anti-DNase antibodies對 NZB/NZW F1及
BABL/c老鼠的影響
討論

參考文獻
自述
著作權聲明

參考文獻
1. Kater, L. and Baart, H.de la Faille, ed. Multi-systemic
autoimmune Derksen, H.W.N., and C. J. M. 1995. Stephens.
Lupus erythematosus. In: disease. 2 th ed. Elsevier Science
B.V., 85-128.
2. Liang, M. H., Socher, S. Larsen, A. M. G. and Schur, P. H. 1989. Reliability and validity of 6 systems for the clinical assessment of disease activity in SLE. Arthritis Rheum. 32: 1107-1118.
3. Bombardier, C. D. D., Gladman, M. B., Urowitz, D., C and C. H. Chang. 1992. Derivation of the SLEDAI: a disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 35: 630-640.
4. Dubois E L. 1978. Antimalarials in the management of discoid and systemic lupus erythematosus. Semin. Arthritis Rheum. 8: 33-51.
5. Bermstein, K. A., Valerio, R. D. and Lefkowith, J. B. 1995. Glomerular binding activity in MRL/lpr serum consists of antibodies that bind to a DNA/histion/type/ IV collagen complex. J. Immunol. 154: 2424-2433.
6. Brian, L. K. 1996. Systemic lupus erythematosus. Cell 85: 303-306.
7. Brinkman, K., Termaat R., Berden, J. H. M., and Smeenk, R. J. T. 1990. Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol. Today 11: 232-234.
8. Suzuki, N., Shoji, M. and Tsuyoshi, S. 1997. Development of pathogenic anti-DNA antibodies in patients with systemic lupus erythematosus. FASEB. 11:1033-1038.
9. Ebling, F., and Hahn, B. H. 1980. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: comparison of antibodies in serum and renal eluates. Arthritis Rheum.23: 392-403.
10. Bruijn, J. A., Bergijk, E. C. DeHerr, E., Fleurence, G. J. and Hoedemaeke,r P. J. 1992 Induction and progression of experimental lupus nephritis: Exploration of a pathogenic pathway. Kidney Int. 41: 5-13
11. Frank, M. M., Hamburger, Lawley, M. I., T. J. Kimberly, R. P., and Plotz, P. H. 1979. Defective reticuloendothelial system Fc-recptor function in systemic lupus erythematosus. N. Engl. J. Med. 300: 518-523.
12. Wilson, J. G. and Fearon, D. T. 1984. Altered expression of complement receptors as a pathogenic factor in systemic lupus erythematosus. Arthritis Rheum. 27: 1321-1328.
13. Theofilopoulos, A.N. and Dixon, F.J. 1985. Murine models for systemic lupus erthematosus. Adv. Immunol. 37: 269-390.
14. Drake, C.G., Roozo, S. J., Vyse,T. J., Palmer, E. P., and Kotin, B. U. 1995. Genetic contributions to lupus-like disease in (NZB/NZW) F1 mice. Immunol. Rev. 144: 51-74.
15. Nygard, N. R. Deborah M. M. Joel, S. and Benjamin, D. S. 1993. Mixed haplotypes and autoimmunity. Immunology Today 14: 53-56.
16. Klinman, D. M. and Steinberg, A. D. 1987. Systemic autoimmune diseasearise from polyclonal B cell activition. J Exp. Med. 165: 1775-1760.
17. Izui, S., McConahey, P. J., and Dixon, F. J. 1978. Increased spontaneous polyclonal activatein of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol. 121: 2213-2219.
18. Kilnman, D. M. 1990. Polyclonal B cells activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J. Clin. Invest. 86: 1249-1254.
19. Reininger, L. Radaskiewicz, T. Kosco M. Melchers, F. and Rolink, A.G. 1992. Development of autoimmune disease in SCID mice populated with long-term "in-vitro" proliferating (NZB/NZW) F1 pre-B cells. J. Exp. Med. 174: 1023-1029.
20. Cyster, J. G., Hartley, S. B., and Goodnow, C. C. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395.
21. Chen, C., Nagy, Z., Radic, M.Z., Hardy, R. R., Huszar, D., Camper S.A. and Weigert M. 1995. The site and stage of anti-DNA B-cell deletion. Nature 373: 252-255.
22. Goodnow, C. C., Cyster, J. G. Hartley, S. B., Bell, S. E., Cooke M. P., Healey, J. I., Akkaraju, S., Rathmell, J. C., Pogue, S. L. and Shokat, K. P. 1995. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59: 279-378.
23. Watangabe-Fukunage, R., Brannan, C. I., Copland, N. G., Jenkins, N. A. and Nagata, S. 1992. Lymphorproliferative disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 356: 314-317.
24. Strasser, A., Whittingham, S., Vaux , D. L., Adams, J. M., Cory, S. and Harrism A. W. 1988. Enforced Bcl-2 expression in B lymphoid cells prolongs antibody responses and exhibits autoimmune disease. Proc. Natl. Acad. Sci. USA 88: 8661-8665.
25. Nisitanim, S., Tsubata, T., Murakami, M., Okamoto, M., and Honjo, T. 1993. The bcl-2 gene product inhibits colonal deletion of self-reactive B lymphocytes in the periphery but not in the bone-mar row. J. Exp. Med. 178: 1247-1254.
26. Romagnami, S. 1992. Induction of Th1 and Th2 response: a key role for the "nature" immune response? Immunol. Today 13: 379-381.
27. Spronk , P. E., Ter, Borg, E. J., Limburg P. C., and Kallenberg C. G. M.1992. Plasma concentration of interleukin-6 in systemic lupus erythematosus: An indictor of disease activity? Clin. Exp. Immunol. 90: 106-110.
28. Nagafuchi, H., Suzuki, N., Mizushima, Y., and Sakane, T., Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151: 6525-6534.
29. Llorente, L., Richaud-Patin, Y., Fior, R., Alcocer-Varela, J., Wijdene,s J., Fourrier, B. M., Galanaud, P., and Emilie, D.1994. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren* syndrome, and systemic lupus erythematosus. Arthritis Rheum. 37: 1647-1655.
30. Ishida, H., Muchamuel, T., Sakaguchi, S., Andradre, S., Menon, S., and Howard, M. 1994. Continous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179: 305-310.
31. Ishida, H., Hastings, R., Kearney, J., and Howard, M. 1992. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175: 1213-1220.
32. Radic, M. Z., Mackle, J., Erickson, J. Anderson, W. F. and Weigert M.1993. Residues that mediate DNA binding of autoimmune antibodies. J. Immunol. 150: 4966-4977.
33. Datta, S. K., Arunan, K. and Ami, DM. 1997. T cells of lupus and molecular targets for immunotherapy. J. Clinc. Immunol. 17: 11-20.
34. Fink, B.K., Linsley, P.S., and Wofsy, D. 1994. Treatment of murine lupus with CTLA4 Ig. Science 265: 1225-1227.
35. Mohan, C., Shi, Y., Laman, J. D., and Datta, S. K. 1995. Interaction between CD4 and its ligand gp39 in the development of murine lupus nephritis. I. Immunol. 154: 1470-1480.
36. Mohan, C., Adams, S., Stanik, V., and Datta, S. K., 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing Tcells of lupus nephritis. J. Exp. Med. 177: 1367-1381.
37. Bockenstedt, L. K., Gee R. J. 1995. Self peptides in the initiation of lupus autoimmunity. J. Immunol. 154: 3516-3524.
38. Sercarz, E. E., Lehmann, P. V., Ametani, A., Benichou, G., Miller, A. and Moudgill, K. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11: 729-766.
39. Hochberg, MC. 1992. Epidemiology of systemic lupus erythematosus, In: Lahita RG (ED) systemic lupus erythematous, 2nd edn. New York, Churchil Livinggstone. 103-117.
40. Arnett, FC. 1993. The genetic basis of lupus erythematous. In: Wallace DJ, Hahn BH (Eds) Dubois lupus erythematosus, 4th edn. Philadelphia, Lea and Febiger. 13-36
41. Lehman, T. J. 1995. A practical guide tosystemic lupus erythematosus. Pediatric Clincs of North America 42: 1223-1236.
42. Arnett, FC. 1993. The genetics basis of lupus erythematosus .in : wallwce DJ. Hahn BH (Eds) Dudois* lupus erthematosus ,4th edn. Philadelphai, Lea and Febiger, 13-36.
43. Arnett, FC, Reveille, JD. 1992. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am. 18(4):865-892.
44. Cook, L. Agenello, V. 1992. Complement deficiency and systemic lupus erythematosus. In : Lahita RG (Ed) Systemic Lupus Erythematosus. 2nd edn. New York, Churchil Livingstone. 569-586.
45. Timothy, J. V., and John, A. T. 1996. Genetic analysis of autoimmune disease. Cell 85: 311-318.
46. Ahmed, S.A., Penhale, W.J., Talal, N. 1985. Sex hormones, immune response, and autoimmune disease: mechanisms of sex hormone action. Am J Pathol. 531-551.
47. Fernandes, G., and Talal, N. 1986. SLE: hormones and diet. Clin. Exp. Rheum. 4: 183-185.
48. Sthoeger, Z., Chiorazzi, N., Lathita, RG. 1988. Regulation of the immune response by sex steroids. J. Immunol. 141: 91-98.
49. Hess, E.V. and Farhey, Y. 1995. Etiology environmental relationships, epidemiology, and genetics of systemic lupus erythematosus. Curr. Opin. Rheumatol. 11:371-375.
50. Petri, M., and Allbritton, J. 1992. Antibodies allergy in systemic lupus erythematosus: a case control study. J. Rheumatol. 19: 265-269.
51. Talan, N., Flescher, E., and Dang, H. 1992. Are endogenous retroviruses involved in human autoimmune disease? J. Autoimmun. 5: 61-66.
52. Ranki, A., Kurki, P., Riepponene, S., and Stephannsson, E. 1992. Antibodies to retroviral proteins in autoimmune connective tissues disease. Arthritis Rheum. 35:1483-1493.
53. Raz, E., Ben-Bassat, H., Davidi, T., Shlomai, Z. and Eila, D. 1993. Cross reaction of anti-DNA autoantibodies with cell surface proteins. Eur. J. Immunol. 23: 383-390.
54. Gladman, D. D. 1995. Prognosis and treatment of systemic lupus erythematous: clinical and laboratory correlation. Curr. Opin. Rheumatol. 7: 402-408.
55. Lacks, S.A., 1981. Deoxyribonuclease I in mammalian tissues. J. Bio. Chem. 256: 2644-2648.
56. Wannamaker, L. W. and Yasmineh. 1967. Streptococcal nuclease I further studies on the A, B and C enzymes. J. Exp. Med. 126: 475-496.
57. Price, P. A., Stein, WH., Moore, S. 1969. Effective of divalent cations on the reduction and reformation of the disulifide bonds of deoxyribonuclease. J. Bio. Chem. 244: 929-932.
58. Love, J. D. and Roger, R. H. 1979. The relationship between human serum and human pancreatic DNase I. J. Bio. Chem. 254: 12588-12594.
59. Drew, H. R. and Trvers, A. A. 1984. DNA structural variations in the E. coil tyr T promoter. 37: 491-502.
60. Oefner, C., and Dietrich, S. 1986. Crystallographic refinement and structure of DNase I at 2 A resolution. J. Mol. Bio. 192: 605-632.
61. Laskowski, M., Sr. 1961 in The Enzymes (Boyer, P. D., Lardy, H., and Myrback, K., eds) 2nd Ed.,Vol. 5,. Academic Press, New York 123-147.
62. Moore, S.1981 in The Enzymes (Boyer,P. D., ed) 3rd Ed., Academic Press, New York Vol. 14: 281-296,
63. Liao, T. H. 1981. Multiple forms of deoxyribonuclease I. Mol. Cell Biochem. 34: 15-22.
64. Liao, T. H. 1997. Deoxyribonuclease I and its clinical applications. J. Formos. Med. Assoc. 96: 481-487.
65. Kishi, K., Toshihiro, Y., Shuichi, A., and Kelko, M.1989. Gentic polymorphism of human urine deoxyribonuclease I. Hum Genet 81: 295-297.
66. Petisch, M.C., Polzar, B. Stephan, T., Crompton, H.R. and Tschopp, J. 1993. Characterization of the endogenous deoxyribonuclease in involvd in nuclear DNA fragmention during apoptosis. EMBO J. 12: 371-377.
67. Miyauchi, K., Ogaawa, M., Murata, A., Nakanon, I., Funakoshi, A., and Mori, T. 1989. Serum deoxyribonuclease I determined by a radioimmunoassay and an enzymatic assay in malignant disease. Clin. Chim. Acta. 184: 115-120.
68. Aitken, ML., Burke, W., McDonald, G., Shak, S., Montdomery, AB. and Smith, A. 1992. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study . JAMA. 267: 1947-1951.
69. Miyauchi, K., Ogaawa, M., Murata, A., Nakanon, I., Funakoshi, A., and Mori, T. Ito, K. Minaniura, N. and Yamamoto. 1986. Development of a radioimmunoassay for human deoxyribonuclease I. Clin. Chim. Acta. 154: 115-123.
70. Scully, C., Spandios, DA., Ward, B. P., McGregor, IA., and Boyle, P. 1981. Serum alkaline deoxyribonuclease in oral cancer and permalignant lesions. Biomedicine 35: 179-180.
71. Zollner, EJ., Muller, WE., and Zahn, RK. 1971. Moglichkiten zur gezitlten diagnose durch beastimmung der sauren deoxyribonuclease im urim gesunder kontrollpersonen und xeroderma pigmentosum-patienten.Klin Wochenscher 49: 1290-1294.
72. Funakoshi, A., Wakasugi, H. and Lbayashi, H. 1979. Clinical investiga.tion of serum deoxyribonuclease LL. Clinical studies of serum deoxyribonuclease activity in pancreatic disease. Gastroenterol Jpn. 14: 434-440.
73. Frost, PG., and Lachmann, PJ. 1968. The relationship of deoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin. Exp. Immunol. 3: 447-455.
74. Chitrabamrung, S., Rubin, RL. and Tan, EM. 1981. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol. Int. 106: 243-252.
75. Aitken, M. L., Wylie, B., Gwen, MD., Steven, S., A. Bruce, M., Arnold, S. 1992 . Recombinant Human DNase Inhalation in Normal Subject and Patients With Cystic Fibrosis. JAMA. 267: 1947-1951.
76. Rubin, R. L., Joslin, F. G. and Tan, E. M. 1983. An improved ELISA for anti-native DNA elimination of interference by antihistone antibodies. J. Immunol. Methods 63: 359-371.
77. Rosenthal, A., L., and Lacks, S. A. 1977. Nuclease detection in SDS-polyacrylamide gel electrophoresis. Analy. Biochem. 80: 76-90.
78. Ito, K., Aminamiura, N., and Yamamoto, T. 1984. Human urine DNase I, and enzymic and protecochemical properties of the enzyme. J. Biochem. 95: 1399-1406.
79. Arden, L., DEGroot, E. R., and Feltkamp, E. W. 1975. Immunology of DNA III. Crithidia lucilia, a simple substrate for the determination of anti-dsDNA with the immunoflourescent technique. Ann. N. Y. Acad. Sci. 254:505-525.
80. Pisetsky, D. S. 1996. The immunologic properties of DNA. J. Immunol. 156: 421-423.
81. Dharmesh, D. D., Meera, R. K. John T. S., and Tony, N. M. 1993. Antigen-specific induction of antibodies against native mammalin DNA in nonautoimmune mice. J. Immunol. 151: 1614-1626.
82. Tan, EM. Schur, PH. Carr, RI. and Kunkel, HG. 1973. The occurence of single-strand DNA in the serum of patients with systemic lupus erythematosus and other disease. J. Clin. Invest. 52:198-204.
83. Macanovic, M. D., Sinicropi, S. S., Baunghman, S. T. and Lachmann, P. J. 1996. The treatment of systemic lupus erythematosus (SLE) in NZB/NZW F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin. J. Immunol. 106:243-252.
84. Carlos, A. Muhlen V. and Tan, E. M. 1995. Autoantibodies in the diagnosis of systemic rheumatic disease. 24: 323-358.
85. Andreas, P., Iris, Z., Annegret, F. and Josephine, W. H. 1996. Molecular characterization of a major serotype M49 Group A streptococcal DNase Gene (sdaD). Infect. Immun. 64: 5349-5356.
86. Lin, J. L., Wang, W. Y., Liao, T. H. 1994. Thermal inactivation of shrimp deoxyribonuclease with and without sodium dodecyl sulfate. Biochim. Biophys. Acta. 1209: 209-214.
87. Marchini, B. Puccetti, A., Dolcher, M. P., Madaio, M. P. and Minglorini, P. 1995. Induction of anti-DNA antibodies in non- autoimmune mice by immunization with a DNA-DNase I complex. Clin. Exp. Rheum. 13: 7-10.
88. Judith, A. J. and John, B. H. 1998. A module of peptide-induced autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice. J. Immunol. 160: 502-508.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
系統版面圖檔 系統版面圖檔